On a Roll: FDA Calls Sage's Depression Drug a Breakthrough Post author:Sam Post published:February 6, 2018 Post category:BioPharma This is the second Breakthrough Therapy designation granted to Sage since 2016. Source: BioSpace You Might Also Like Neurotrope Poaches Forest Lab Exec to Be CEO December 17, 2017 Array BioPharma And Bristol-Myers Squibb Announce Strategic Collaboration May 29, 2017 Standardizing On Veeva Systems, Inc. Vault Enhances Regeneron???s Clinical And Regulatory Operations Processes June 18, 2017
Standardizing On Veeva Systems, Inc. Vault Enhances Regeneron???s Clinical And Regulatory Operations Processes June 18, 2017
